Search

everythinglearnresearchcommunity

for

Search:↓

The treatment is safe and shows promise for metastatic breast cancer.

TCDD changes skin cell growth and keratin production in mice.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Gefitinib can cause hair loss without scarring.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

ITK inhibitors may effectively treat alopecia areata.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Tofacitinib treatment is used for teenagers with alopecia areata.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Blocking YAP/TAZ could be a new way to treat skin cancer.

A group has developed therapies that show promise for treating cancer and various other conditions.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.